Intellia Therapeutics Sponsored Webinar

Explore unmet needs in ATTR amyloidosis with polyneuropathy and the evolving therapeutic landscape. This expert-led webinar will provide a comprehensive clinical overview of ATTRv-PN. Current treatment strategies and their limitations will be discussed, and the potential utility of investigational treatment approaches, including CRISPR, which is designed to target disease at its root cause, will be explored. The faculty will also discuss best practices and established clinical methods for accurately assessing disease progression, emphasizing the importance of multidisciplinary care in supporting early diagnosis, treatment, and disease monitoring.